Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia

Arteriosclerosis, Thrombosis, and Vascular Biology
P ErikssonA Hamsten

Abstract

Hypertriglyceridemia and impaired fibrinolytic function are linked to coronary heart disease and other atherothrombotic disorders. Triglyceride-rich lipoproteins may attenuate fibrinolysis by increasing the plasma levels of plasminogen activator inhibitor-1 (PAI-1). Furthermore, a common 4/5 guanosine (4G/5G) polymorphism in the promoter region of the PAI-1 gene has been indicated to influence plasma PAI-1 activity and to be involved in an allele-specific response to triglycerides. Herein we show by transfection assays that VLDLs induce transcription of the human PAI-1 promoter in endothelial cells. A VLDL response element (VLDLRE) is located to residues -672 to -657 in the promoter region by electromobility shift assay, methylation interference, and DNase I footprinting, and its activity is shown to be influenced by the common 4G/5G polymorphism located adjacent to and upstream of the binding site of a VLDL-inducible transcription factor. These findings may provide a molecular explanation to the link between VLDL and PAI-1 activity elevation in plasma and to the interaction between the 4G/5G polymorphism and plasma triglycerides.

References

Oct 1, 1977·Analytical Biochemistry·V F Kalb, R W Bernlohr
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M GöttlicherJ A Gustafsson
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J SchneidermanD J Loskutoff
Nov 1, 1991·Progress in Cardiovascular Diseases·B Wiman, A Hamsten
Sep 1, 1990·Atherosclerosis·M MehrabianA J Lusis
Nov 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A Stiko-RahmJ Nilsson
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·P ErikssonA Hamsten
Apr 1, 1994·Molecular and Cellular Endocrinology·S Green, W Wahli
Sep 1, 1994·Journal of the American College of Cardiology·K MalmbergA Hamsten
Mar 1, 1993·The Journal of Clinical Investigation·F KarpeA Hamsten

❮ Previous
Next ❯

Citations

Jul 5, 2001·Biochemical and Biophysical Research Communications·A M SawkaT O'Brien
Aug 8, 2013·European Journal of Nutrition·Antonio CamargoJose Lopez-Miranda
Nov 2, 2001·Atherosclerosis·R A AndersonJ Goodfellow
Sep 10, 2003·The Journal of Laboratory and Clinical Medicine·Chih-Hung ChenTsun-Mei Lin
May 10, 2003·Journal of Molecular and Cellular Cardiology·John A SchoenhardDouglas E Vaughan
Nov 19, 2003·Metabolism: Clinical and Experimental·Małgorzata Kozłowska-WojciechowskaAnna Foltyńska
Dec 13, 2002·Journal of Diabetes and Its Complications·Jorge PlutzkySteven Haffner
Jun 5, 2002·Atherosclerosis. Supplements·Fredrik Karpe
Dec 10, 1998·Journal of Internal Medicine·M R Taskinen, U Smith
Dec 3, 1999·Journal of Internal Medicine·F Karpe
Jun 26, 2001·Journal of Internal Medicine·A JohanssonT Olsson
Mar 22, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·M S FreemanP J Grant
Jun 15, 2000·The New England Journal of Medicine·H P Kohler, P J Grant
Feb 19, 2000·Current Opinion in Lipidology·G F Watts, S B Dimmitt
Mar 17, 2004·Current Opinion in Lipidology·Barbara Voetsch, Joseph Loscalzo
Jan 30, 2004·Southern Medical Journal·Josef FinstererPiere Hopmeier
Jan 7, 2005·Journal of Thrombosis and Haemostasis : JTH·H R Lijnen
Jan 20, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Frances M K WilliamsUNKNOWN EuroCLOT Investigators
Aug 23, 2000·The Journal of Clinical Investigation·H N Ginsberg
May 8, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinji MorimotoTadaaki Iwasaki
Jun 27, 2009·Journal of Atherosclerosis and Thrombosis·Yoshio Fujioka, Yuichi Ishikawa
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·D E Vaughan
Jul 5, 2005·Biochemical and Biophysical Research Communications·Yu-Hua ZhaoYu Liu
Oct 13, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jing ChenYan-Li He
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Rasaq Olufadi, Christopher D Byrne
Apr 23, 2008·Journal of Cardiovascular Pharmacology·Madiha Abdel-MaksoudJohn E Hokanson
Mar 29, 2014·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Ioannis KyrgiosAssimina Galli-Tsinopoulou
Aug 2, 2017·International Journal of Molecular Sciences·Yao YeViktoria von Schönfeldt
Jul 28, 2010·Therapeutic Advances in Cardiovascular Disease·Nancy J Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.